1. Home
  2. NVX vs KALA Comparison

NVX vs KALA Comparison

Compare NVX & KALA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NOVONIX Limited American Depository Shares

NVX

NOVONIX Limited American Depository Shares

HOLD

Current Price

$0.62

Market Cap

144.3M

Sector

Miscellaneous

ML Signal

HOLD

Logo KALA BIO Inc.

KALA

KALA BIO Inc.

HOLD

Current Price

$2.69

Market Cap

172.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NVX
KALA
Founded
2012
2009
Country
Australia
United States
Employees
192
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
144.3M
172.0M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
NVX
KALA
Price
$0.62
$2.69
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
$31.50
AVG Volume (30 Days)
273.1K
2.4M
Earning Date
04-30-2026
04-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
67.39
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$3,904.19
N/A
Revenue Next Year
$91.72
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.59
$0.07
52 Week High
$3.86
$20.58

Technical Indicators

Market Signals
Indicator
NVX
KALA
Relative Strength Index (RSI) 38.56 69.05
Support Level $0.62 $0.32
Resistance Level $0.76 $3.96
Average True Range (ATR) 0.04 0.28
MACD -0.01 0.17
Stochastic Oscillator 23.83 66.65

Price Performance

Historical Comparison
NVX
KALA

About NVX NOVONIX Limited American Depository Shares

NOVONIX Ltd is a battery technology company developing and scaling materials and equipment critical to the lithium-ion battery supply chain. The company has three operating segments: Battery Materials: It develops and manufactures battery anode materials, ii) Battery Technology: It develops and manufactures battery cell testing equipment, performs consulting services and carries out research and development in battery development, and Graphite Exploration: It manages the maintenance and future development of Mount Dromedary natural graphite deposit. The majority of the company's revenue is derived from the Battery Technology segment. Geographically, the maximum revenue is derived from North America, followed by Asia, and Europe.

About KALA KALA BIO Inc.

Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

Share on Social Networks: